EASOU TECH (02550) plans to use no more than HK$20 million to repurchase shares on the open market.
Yisoo Technology (02550) announced that it intends to exercise the general power granted by the resolution passed by the company's shareholders at the annual general meeting held on June 27, 2025, to repurchase the company's ordinary shares (buyback authorization). Under the buyback authorization, the directors may exercise the power to repurchase shares of the company, but not exceeding 10% of the total number of shares issued on the day of the shareholders' annual general meeting where the relevant resolution was passed.
EASOU TECH (02550) announced that it intends to exercise the power granted by the resolution passed at the company's annual general meeting of shareholders held on June 27, 2025, to authorize the Board of Directors to repurchase the company's ordinary shares (repurchase authorization). According to the repurchase authorization, the Directors may repurchase shares up to a maximum of 10% of the total number of shares issued on the day of the shareholders' annual general meeting where the resolution was passed.
The Board of Directors has decided, depending on market conditions, that the company intends to utilize up to HK$20 million under the repurchase authorization and (if applicable) any general authorization presented for the repurchase of shares at the company's forthcoming annual general meeting of shareholders to be held on June 30, 2026, to repurchase shares on the open market from the date of this announcement for a period of six months. The company will fund the share repurchase from its existing available cash reserves and intends to hold any shares repurchased under the repurchase plan as treasury shares, which may subsequently be canceled, sold, or transferred, including for the funding of the 2025 Employee Stock Award Plan II.
Related Articles

Sinolink: In June, the market will wait in volatility for the moment of validation.

GF SEC: Four switches behind the assets

Sinovac Biotech Ltd. (02493) proposes to elect Tang Chunshan, Liu Datao, Wu Hai, and Hua Jun as executive directors.
Sinolink: In June, the market will wait in volatility for the moment of validation.

GF SEC: Four switches behind the assets

Sinovac Biotech Ltd. (02493) proposes to elect Tang Chunshan, Liu Datao, Wu Hai, and Hua Jun as executive directors.






